NeuroMind AGI
Every critical system is monitored in real time. The human operator is not.
Objective neurofunctional monitoring for Cognitive Warfare and Human Performance Optimization (HPO).
Defense · Aerospace · Cyber Operations · Healthcare
The Problem
Questionnaires are gameable. Wearables measure proxies. Standard clinical tests miss what matters most.
Wearables tracking heart rate, sleep, movement. Questionnaires. Neuropsychological tests. Clinical interviews.
Self-reported data is gameable. Wearables measure physiological proxies — not actual cognitive function. Standard tools miss compensated dysfunction.
An objective, explainable, regulation-aligned system that reads neurofunctional state directly from brain activity — and translates it into an operational decision.
No player owns this layer. NeuroMind AGI does.
The Solution
Software-only. No hardware. No devices. Runs on any certified third-party EEG headset.
The software intelligence layer between raw brain activity and an operational decision — objective, explainable, designed for regulated environments.
Proprietary neurofunctional pipeline processes EEG signals and extracts objective indicators of cognitive state — attention, fatigue, overload, degraded decision capacity.
AI operates at the inference layer — supervised ML models classify neurofunctional indicators derived from ERP-based EEG protocols. Expert logic ensures interpretability.
Every AI-generated output is reviewed by a human specialist, enabling function as a decision-support system in regulated environments.
The Science
95% classification accuracy — including cognitive profiles invisible to every standard clinical tool. (Marconi · Pessa · Penna — IEEE MEMEA 2018)
27 subjects assessed with full clinical tools. Conventional tools identified two groups. Neurophysiological analysis revealed three — including masked subjects showing objective impairment detectable only through ERP-based EEG indicators.
Standard tools: Questionnaires 70% · Clinical rating scales 80% · Neuropsychology 60% · EEG neurofunctional method: 95%. The breakthrough comes from the neurophysiological method — not from data volume. Patent filed January 2026.
The pilot who passes standard screening. The cyber analyst within range on every questionnaire. The surgeon with no red flags. NeuroMind detects what standard tools cannot see.
One Platform. Dual-Use.
Deployed across defense, cyber, aerospace, enterprise leadership, and healthcare environments.
Standardized neurofunctional assessment engine generating objective cognitive performance indicators
Explainable AI models translating neurofunctional signals into operationally relevant metrics
Modular interpretation layer adapted to mission context and operational domain
Defense operations — pilots, drone operators, naval crews, special forces
Cyber operations — SOC analysts and cyber defense teams
Space operations — satellite mission control operators
Enterprise leadership — executives and critical decision roles
Healthcare diagnostics — psychiatry and neurocognitive evaluation
Our Team
The operational, financial, legal, and clinical execution team.
C-Suite
25 years in digital transformation, AI, strategic innovation. Former executive at Microsoft, Open Fiber, FS. One of 17 global Digital Transformation SMEs (Microsoft). Advisor in two Italian governments. Knight of the Order of Merit (2021).
34 years in medicine, psychiatry, neuroscience. Pioneer in AI diagnostics and EEG analysis. Lead author IEEE MEMEA 2018. Professor, Sapienza University. Founder, Artemis Neurosciences.
20 years in clinical research. Designs and oversees clinical trials and hospital partnerships. Manages national and EU-funded research programs.
25 years in finance and corporate governance. Former Director AIFA (2006–2014). EMA/AIFA regulatory expertise. Court-Appointed Technical Consultant.
10 years in corporate governance and regulatory compliance. Former legal advisor, Italian Senate Health Committee. Healthcare law and EU compliance expert.
Contact
